Search - tctmd.com

Displaying 801 - 820 of 1003

Sort: Relevancy | Date

Presentation TCT 2013

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Presenter: Tim van de Hoef

October 31, 2013

Presentation TCT 2013

Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes

Presenter: Michael Lim

October 30, 2013

Presentation TCT 2013

Integrating IVUS and FFR into the Appropriate Use Criteria

Presenter: Allen Jeremias

October 30, 2013

Presentation TCT 2013

How I Integrate FFR and IVUS in the Cath Lab and Why

Presenter: Soo-Jin Kang

October 30, 2013

Presentation TCT 2013

HeartFlowNXT: A Prospective, Registry Evaluation of Noninvasive FFRCT vs. Invasive FFR

Presenter: Bjarne N?rgaard

October 30, 2013

Presentation TCT 2013

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Presenter: Pim Tonino

October 30, 2013

Presentation TCT 2013

FFR in Patients with Previous Noninvasive Tests: How Do I Integrate Invasive and Noninvasive Assessment of Ischemia?

Presenter: Morton Kern

October 30, 2013

Presentation TCT 2013

FFR in Patients with Acute Coronary Syndromes

Presenter: Habib Samady

October 30, 2013

Presentation TCT 2013

FFR in Non-Left Main Bifurcation Lesions

Presenter: Bon-Kwon Koo

October 30, 2013

Presentation TCT 2013

FFR in Left Main Disease

Presenter: Andy Yong

October 30, 2013

Presentation TCT 2013

FFR Clinical Trials: Review and Update

Presenter: William Fearon

October 30, 2013

Presentation TCT 2013

Case Presentation: A Case Where I Needed Both IVUS and FFR

Presenter: Justin Davies

October 30, 2013

Presentation TCT 2013

Case #5: FFR Has an Important Role in Side Branch Stenting!

Presenter: Indulis Kumsars

October 30, 2013

Presentation TCT 2013

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Presenter: Javier Escaned

October 30, 2013

Presentation TCT 2013

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Presenter: Nils P. Johnson

October 29, 2013

Presentation TCT 2013

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

Presenter: Colin Berry

October 29, 2013

Presentation TCT 2013

TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment

Presenter: Jeremiah Depta

October 29, 2013

Presentation TCT 2013

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

Presenter: Colin Berry

October 29, 2013

Presentation TCT 2013

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

Presenter: Guus Waard

October 29, 2013

Advertisement

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes

Integrating IVUS and FFR into the Appropriate Use Criteria

How I Integrate FFR and IVUS in the Cath Lab and Why

HeartFlowNXT: A Prospective, Registry Evaluation of Noninvasive FFRCT vs. Invasive FFR

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

FFR in Patients with Previous Noninvasive Tests: How Do I Integrate Invasive and Noninvasive Assessment of Ischemia?

FFR in Patients with Acute Coronary Syndromes

FFR in Non-Left Main Bifurcation Lesions

FFR in Left Main Disease

FFR Clinical Trials: Review and Update

Case Presentation: A Case Where I Needed Both IVUS and FFR

Case #5: FFR Has an Important Role in Side Branch Stenting!

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

TCT-84. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial: Study...

TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment

TCT-82. Fractional Flow Reserve versus Angiography in Guiding Management to Optimize Outcomes in Non-ST Elevation Myocardial Infarction (FAMOUS – NSTEMI) Clinical Trial:...

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content